$18.735
-0.085[-0.45%]
Last update: 1:07PM Get Real Time Here
Avadel Pharmaceuticals
(NASDAQ:AVDL)Latest News for Avadel Pharmaceuticals Stock (NASDAQ:AVDL)
Avadel Pharmaceuticals Stock (NASDAQ: AVDL)
Categories: All
Tuesday, April 09, 2024
Thursday, March 28, 2024
Tuesday, March 05, 2024
- American Airlines To Rally Around 42%? Here Are 10 Top Analyst Forecasts For TuesdayAvi Kapoor - Mar 5, 2024, 9:30AM
- Craig-Hallum Maintains Buy on Avadel Pharmaceuticals, Raises Price Target to $22Benzinga Newsdesk - Mar 5, 2024, 9:22AM
- Avadel Pharmaceuticals Analysts Increase Their Forecasts After Q4 ResultsAvi Kapoor - Mar 5, 2024, 7:52AM
- Oppenheimer Maintains Outperform on Avadel Pharmaceuticals, Raises Price Target to $29Benzinga Newsdesk - Mar 5, 2024, 7:46AM
- HC Wainwright & Co. Maintains Buy on Avadel Pharmaceuticals, Raises Price Target to $25Benzinga Newsdesk - Mar 5, 2024, 6:51AM
- Piper Sandler Maintains Overweight on Avadel Pharmaceuticals, Raises Price Target to $23Benzinga Newsdesk - Mar 5, 2024, 6:39AM
- Needham Maintains Buy on Avadel Pharmaceuticals, Raises Price Target to $22Benzinga Newsdesk - Mar 5, 2024, 6:28AM
Monday, March 04, 2024
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga Insights - Mar 4, 2024, 4:32PM
- CORRECTION: Jury Ruled In Favor Of Avadel With Respect To One Of The Contested PatentsBenzinga Newsdesk - Mar 4, 2024, 3:52PM
- Avadel Says Does Not Expect The Jury's Decision To Impact The Ongoing Commercial Launch Or Potential For LUMRYZ To Transform The Lives Of People Living With Narcolepsy.Benzinga Newsdesk - Mar 4, 2024, 3:41PM
- Avadel Pharmaceuticals Issues Statement On Patent Litigation; Statement In Response To Jury Ruling In Patent Suit Brought By Jazz Pharmaceuticals Inc. Regarding LUMRYZBenzinga Newsdesk - Mar 4, 2024, 3:39PM
- Watching Avadel Pharmaceuticals; Shares Spike Higher On VolumeBenzinga Newsdesk - Mar 4, 2024, 3:09PM
- Avadel Pharmaceuticals shares are trading higher after the company reported better-than-expected Q4 revenue results.Benzinga Newsdesk - Mar 4, 2024, 7:34AM
- Avadel Pharmaceuticals Q4 EPS $(0.32) Misses $(0.29) Estimate, Sales $19.45M Beat $18.11M EstimateBenzinga Newsdesk - Mar 4, 2024, 6:33AM
- Earnings Scheduled For March 4, 2024Benzinga Insights - Mar 4, 2024, 4:53AM
Friday, March 01, 2024
Tuesday, February 06, 2024
Wednesday, January 17, 2024
Monday, January 08, 2024
Wednesday, December 20, 2023
Thursday, November 09, 2023
Wednesday, November 08, 2023
- Avadel Pharmaceuticals Sees Robust Uptake For Its Newly Approved Sleep Disorder DrugVandana Singh - Nov 8, 2023, 1:18PM
- Avadel Pharmaceuticals shares are trading higher following Q3 earnings.Benzinga Newsdesk - Nov 8, 2023, 11:16AM
- Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On WednesdayLisa Levin - Nov 8, 2023, 11:02AM
- Avadel Pharmaceuticals Q3 EPS $(0.41) Vs $(0.33) Last Year, Sales $7.01M Beat $5.09M EstimateBenzinga Newsdesk - Nov 8, 2023, 7:02AM
- Earnings Scheduled For November 8, 2023Benzinga Insights - Nov 8, 2023, 4:21AM
Tuesday, November 07, 2023
Friday, October 20, 2023
Wednesday, October 04, 2023
Monday, September 25, 2023
Friday, August 11, 2023
Thursday, August 10, 2023
- Piper Sandler Maintains Overweight on Avadel Pharmaceuticals, Raises Price Target to $18Benzinga Newsdesk - Aug 10, 2023, 3:32PM
- Analyst Expectations for Avadel Pharmaceuticals's FutureBenzinga Insights - Aug 10, 2023, 9:00AM
- Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $18 Price TargetBenzinga Newsdesk - Aug 10, 2023, 6:50AM
- HC Wainwright & Co. Reiterates Buy on Avadel Pharmaceuticals, Maintains $21 Price TargetBenzinga Newsdesk - Aug 10, 2023, 6:41AM
Wednesday, August 09, 2023
- Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $18 Price TargetBenzinga Newsdesk - Aug 9, 2023, 10:23AM
- Avadel Pharmaceuticals Q2 EPS $(0.83) May Not be Comparable To $(0.38) Estimate, Sales $1.50M Beat $630.00K EstimateBenzinga Newsdesk - Aug 9, 2023, 7:09AM
- Earnings Scheduled For August 9, 2023Benzinga Insights - Aug 9, 2023, 4:54AM
Monday, August 07, 2023
Monday, July 03, 2023
Friday, June 30, 2023
- Analyst Expectations for Avadel Pharmaceuticals's FutureBenzinga Insights - Jun 30, 2023, 10:00AM
- Oppenheimer Maintains Market Outperform on Avadel Pharmaceuticals, Raises Price Target to $25Benzinga Newsdesk - Jun 30, 2023, 8:14AM
- Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $18 Price TargetBenzinga Newsdesk - Jun 30, 2023, 6:10AM